1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.67%
Positive revenue growth while 1097.HK is negative. John Neff might see a notable competitive edge here.
37.54%
Gross profit growth under 50% of 1097.HK's 78.75%. Michael Burry would be concerned about a severe competitive disadvantage.
106.77%
EBIT growth above 1.5x 1097.HK's 27.85%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
-3.87%
Negative operating income growth while 1097.HK is at 27.85%. Joel Greenblatt would press for urgent turnaround measures.
104.84%
Net income growth above 1.5x 1097.HK's 20.33%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
104.88%
EPS growth above 1.5x 1097.HK's 21.57%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
104.88%
Diluted EPS growth above 1.5x 1097.HK's 21.57%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.29%
Share reduction more than 1.5x 1097.HK's 1.47%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.29%
Diluted share reduction more than 1.5x 1097.HK's 1.47%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
24.80%
OCF growth under 50% of 1097.HK's 91.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
22.77%
FCF growth under 50% of 1097.HK's 64.60%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-46.01%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
11235.06%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
861.29%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-130.40%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
40.30%
Positive OCF/share growth while 1097.HK is negative. John Neff might see a comparative advantage in operational cash viability.
32.39%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-94.86%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
120.89%
Positive 5Y CAGR while 1097.HK is negative. John Neff might view this as a strong mid-term relative advantage.
101.17%
3Y net income/share CAGR above 1.5x 1097.HK's 42.71%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-9.56%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-24.09%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Negative 5Y dividend/share CAGR while 1097.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.60%
We show growth while 1097.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-4.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.16%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-71.03%
We’re deleveraging while 1097.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
132.92%
SG&A growth well above 1097.HK's 1.82%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.